Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2971051 | The Journal of Heart and Lung Transplantation | 2011 | 9 Pages |
Abstract
Use of iNO at 40 ppm in the perioperative phase of LVAD implantation did not achieve significance for the primary end point of reduction in RVD. Similarly, secondary end points of time on mechanical ventilation, hospital or intensive care unit stay, and the need for RVAD support after LVAD placement were not significantly improved.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Evgenij MD, PhD, Dan MD, Madhav MD, Michael MD, Aly MD, Christoph MD, Bryan DO, Igor D. MD, Marian MD, Tom W. MD, Nandor MD, PhD, Kanti MD, James S. MD, Mark J. MD, Roland MD, PhD,